Literature DB >> 24565957

Ethics of facial transplantation revisited.

Kathy L Coffman1, Maria Z Siemionow.   

Abstract

PURPOSE OF REVIEW: There have been 26 cases of facial transplantation reported, and three deaths, 11.5%. Mortality raises the issue of risk versus benefit for face transplantation, a procedure intended to improve quality of life, rather than saving life. Thus, one of the most innovative surgical procedures has opened the debate on the ethical, legal, and philosophical aspects of face transplantation. RECENT
FINDINGS: Morbidity in face transplant recipients includes infections and metabolic consequences. No graft loss caused by technical failure, hyperacute, or chronic graft rejection or graft-versus-host disease has been reported. One case of posttransplant lymphoproliferative disorder, 3.45% and one case of lymphoma in an HIV-positive recipient were reported. Psychological issues in candidates can include chronic pain, mood disorders, preexisting psychotic disorders, post-traumatic stress disorder (PTSD), and substance abuse.
SUMMARY: Early publications on ethical aspects of face transplantation focused mainly on informed consent. Many other ethical issues have been identified, including lack of coercion, donor family consent and confidentiality, respect for the integrity of the donor's body, and financial promotion of the recipient and transplant team, as well as the cost to society for such a highly technical procedure, requiring lifelong immunosuppression.

Entities:  

Mesh:

Year:  2014        PMID: 24565957     DOI: 10.1097/MOT.0000000000000058

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  6 in total

Review 1.  Key psychosocial challenges in vascularized composite allotransplantation.

Authors:  Martin Kumnig; Sheila G Jowsey-Gregoire
Journal:  World J Transplant       Date:  2016-03-24

Review 2.  The decade of face transplant outcomes.

Authors:  Maria Siemionow
Journal:  J Mater Sci Mater Med       Date:  2017-03-16       Impact factor: 3.896

3.  Psychosocial factors and medication adherence among recipients of vascularized composite allografts.

Authors:  Sarah E Van Pilsum Rasmussen; Alexander Ferzola; Carisa M Cooney; Jaime T Shores; Wp Andrew Lee; Emily Goldman; Christina L Kaufman; Gerald Brandacher; Dorry L Segev; Macey L Henderson
Journal:  SAGE Open Med       Date:  2020-07-09

Review 4.  Ethical Considerations of Whole-Eye Transplantation.

Authors:  Wesley N Sivak; Edward H Davidson; Chiaki Komatsu; Yang Li; Maxine R Miller; Joel S Schuman; Mario G Solari; Gerard Magill; Kia M Washington
Journal:  J Clin Ethics       Date:  2016

5.  The Ethics of Facial Allotransplantation: A Systematic Review.

Authors:  Xiangxia Liu; Sarah Langsdon; Wesley Holloway; Shuqia Xu; Qing Tang; Yangbin Xu; Sai Ram Velamuri; William Hickerson
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-10-31

Review 6.  Cell therapy in vascularized composite allotransplantation.

Authors:  Madonna Rica Anggelia; Hui-Yun Cheng; Ping-Chin Lai; Yun-Huan Hsieh; Chih-Hung Lin; Cheng-Hung Lin
Journal:  Biomed J       Date:  2022-01-15       Impact factor: 7.892

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.